Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats

This publication has 42 references indexed in Scilit:

• Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism
  Diabetologia, 1994
• Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: Effect on nerve function
  Journal of Diabetes and its Complications, 1993
• Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy
  Journal of Diabetes and its Complications, 1993
• Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats
  British Journal of Pharmacology, 1992
• Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats
  Diabetes, 1992
• Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat
  Metabolism, 1991
• A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy
  Diabetologia, 1990
• THE EFFECT OF ALDOSE REDUCTASE INHIBITION ON THE PATTERN OF NERVE CONDUCTION DEFICITS IN DIABETIC RATS
  Quarterly Journal of Experimental Physiology, 1989
• Pathogenesis and prevention of diabetic neuropathy
  Diabetes/Metabolism Research and Reviews, 1988
• The effects of Sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat
  Diabetologia, 1986